More recently, it has been proposed that the serum VAP-1/SSAO concentration is increased in subjects with pre-diabetes in order to counteract hyperglycemia since its increase accompanies that of adiponectin (an adipokine that improves insulin sensitivity) and is negatively associated with incident diabetes [26]. The gene discussed is ADIPOQ; the disease is diabetes mellitus.